Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Vanadium, cobalt and strontium additives for use in aluminum back solar cell contacts
Client-managed group communication sessions within a wireless communications system
Means to securely fixate pacing leads and/or sensors in vessels
Flexible quantization
Monitoring agent programs in a distributed computing platform
Methods for testing OData services
Methods and systems for delivering customized advertisements
  Randomly Featured Patents
Electrical interconnect for a head/arm assembly of computer disk drives
Spray valve arrangement
Method for forming ultra-shallow doping regions by solid phase diffusion
Continuous low flow rate fluid dispenser
Apparatus for contacting a liquid with a gas
Networked computer system for communicating and operating in a virtual reality environment
Substrate processing apparatus
Standard substance for optical calibration and method of making same
Preparing method of IC card and IC card
Signal for industrial surveys